There's major money behind efforts to speed the next significant obesity company to the market. First, it was Metsera, which ...

Obesity startup Metsera is getting a new manufacturing partner and a new CEO. On Tuesday, the well-funded startup announced ...

A New York federal judge dismissed allegations on Monday that Bristol Myers Squibb purposely delayed Breyanzi’s approval to ...

IGM Biosciences will stop working in cancer and shrink its T cell engager pipeline to focus on autoimmune diseases, the ...

A court ruling Friday will open the door to the FDA more tightly regulating stem cell clinics and a commonly-used stem cell ...

California Gov. Gavin Newsom vetoed bipartisan legislation on Saturday that would have reformed pharmacy benefit managers in ...

Pfizer will continue shrinking its ownership in the British consumer health company Haleon, according to an announcement ...

Johnson & Johnson has called off plans to implement a new rebate model for 340B drug price discounts following threats from ...

Kezar Life Sciences is suspending enrollment and dosing in a lupus trial after four patients died in the mid-stage study of ...

Ge­nom­ic med­i­cines start­up En­so­ma is shut­ter­ing its Copen­hagen site and al­so elim­i­nat­ing “a very small num­ber” ...

As the potential end of Robert Califf's time as FDA commissioner nears, he and a key deputy are continuing to push forward ...

Poseida Therapeutics said that 21 of 23 patients (91%) responded to the allogeneic CAR-T therapy it’s developing with Roche ...